Contraline, Inc.
Last verified 2026-06-13. JSON
| Total raised | $55.8M |
|---|---|
| Latest round | Funding round, $55.8M, 2026-06-10 |
| Founded | unknown |
| Headquarters | CHARLOTTESVILLE, VA |
| Industry | biotechnology |
| Stage | unknown |
| Website | contraline.com |
Contraline develops investigational male contraceptives, including a daily topical gel that pauses sperm production and ADAM, a long-acting, non-hormonal, reversible implant. It serves men and couples sharing contraceptive responsibility. Its edge is bringing reversible male contraception to a market little changed beyond condoms and vasectomy.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-06-10 | Funding round | $55.8M | undisclosed |
Detected tech stack
contentful, hsts, react, vercel
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $55.8M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $55.8M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | contraline.com, read 2026-06-13 |
| Description | self-reported | contraline.com, read 2026-06-13 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $55.8M, 2026-06-10 → Funding round, $55.8M, 2026-06-10, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $55.8M, 2026-06-10 → Funding round, $55.8M, 2026-06-10 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes